Korean J Anesthesiol Search


Korean Journal of Anesthesiology 1996;31(6):726-732.
DOI: https://doi.org/10.4097/kjae.1996.31.6.726   
The Study for Renal Effects of Increased Serum and Urinary Inorganic Fluoride Levels after Prolonged Sevoflurane Anesthesia.
Sunk Hun Yoon, Jeong Bae Yoon, Tae Sung Kim, Hyun Soo Kim, Kwang Min Kim
Department of Anesthesiology, Hallym University, College of Medicine, Seoul, Korea.
Sevoflurane (CH2F-O-CH(CF3)2) is a fluorinated derivative of ethyl isoprophyl ether. Sevoflurane has a blood/gas partition coefficient of 0.60 that allows a rapid induction and emergence of anesthesia. But sevoflurane is metabolized to inorganic fluoride known as the etiologic agent of anesthetic nephrotoxicity, more than halothane and isoflurane. It is not known whether sevoflurane biotransformation produce high inorganic plasma fluoride level, thus increasing the potential for fluoride-induced renal dysfunction. The aim of this prospective study was to dertermine the levels of serum inorganic fluoride and the influnce of renal function after prolonged sevoflurane anesthesia METHODS: In this study the serum and urine inorganc fluoride ions concentration were measured before, during, and after sevoflurane anesthesia, respectively, with urine volume and osmolarity in the prolonged sevoflurane anesthesia group (brain aneurysm patients, n=6, anesthetic time: 360 min).
The peak serum fluoride concentration was 71.68 microgrammol/L, 6 hours during anesthesia and then the concentration of serum inorganic fluoride decreased quickly. Peak urinary fluoride concentration was 1344+/-303.29 microgrammol/L, 8 hours after cessation of sevoflurane anesthesia, and its concentration was less than 100 microgrammol/L on the third postoperative day. No evidence of abnormal hepatorenal function occurred in the postoperative period.
Anesthesia with sevoflurane is safe without significant adverse effects in the patients. Although the mean peak serum fluoride levels were 71.68 microgrammo l/L no evidence of abnormal renal function occurred in any of the patients in the postoperative period.
Key Words: Anesthetics; volatile sevoflurane; Kidney nephrotoxicity


Browse all articles >

Editorial Office
101-3503, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-792-5128    Fax: +82-2-792-4089    E-mail: journal@anesthesia.or.kr                

Copyright © 2024 by Korean Society of Anesthesiologists.

Developed in M2PI

Close layer
prev next